CRP and type 2 diabetes mellitus: An increased level of C-reactive protein stipulated the occurrence of inflammatory disturbances, however, treatment with SR (50 and 100 mg/kg) could significantly (p < 0.01) decrease the C-reactive protein levels in T2D rats.